Documentos relacionados

1. [Analysis of causes of graft loss in 135 kidney transplant recipients].
2. Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection.
3. A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
4. Prolonged immunosuppression does not improve risk of sensitization or likelihood of retransplantation after kidney transplant graft failure.
5. Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56^dimCD16^bright natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
6. A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure.
7. Do we need to treat chronic active T cell-mediated rejection?
8. Immune landscape of the kidney allograft in response to rejection.
9. Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry.
10. Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.